Firm expands its global healthcare innovation platform through growth capital, commercialization, and strategic partnerships

公司通过增长资本、商业化及战略合作伙伴关系，扩展其全球医疗健康创新平台

NORMAN, Okla.

俄克拉荷马州诺曼

,

，

Aug. 5, 2026

2026年8月5日

/PRNewswire/ -- Boyd Street Capital today announced the launch of

/美通社/ -- Boyd Street Capital 今日宣布启动

HealthTech Platform Fund II

健康科技平台基金二期

, a $100 million target growth capital fund dedicated to investing in growth-stage healthcare technology companies developing innovative solutions across artificial intelligence, digital health, medical devices, diagnostics, healthcare software, and healthcare infrastructure.

，一只规模为1亿美元的目标增长资本基金，致力于投资于处于成长阶段的医疗健康科技公司，这些公司正在人工智能、数字健康、医疗设备、诊断技术、医疗软件以及医疗基础设施等领域开发创新解决方案。

The launch of HealthTech Platform Fund II marks a defining milestone in Boyd Street Capital's Mission 2030 strategy to build a globally connected healthcare innovation platform. By integrating growth capital, commercialization expertise, an integrated Venture Studio, and strategic partnerships across research institutions, health systems, industry, and capital providers, the firm is creating an ecosystem designed to accelerate the translation of healthcare innovation from discovery to patient care..

HealthTech Platform Fund II 的启动标志着博伊德街资本（Boyd Street Capital）“2030使命”战略中的一个决定性里程碑，该战略旨在构建一个全球互联的医疗健康创新平台。通过整合增长资本、商业化专业知识、一体化创业工作室，以及与研究机构、医疗体系、产业界和资本提供方建立的战略合作伙伴关系，该公司正在打造一个旨在加速医疗健康创新从发现到患者护理转化的生态系统。

More than a venture fund, HealthTech Platform Fund II serves as the growth capital engine powering a broader platform focused on advancing healthcare innovation worldwide. The platform connects research institutions, health systems, industry, entrepreneurs, family offices and capital into a single commercialization ecosystem designed to accelerate the translation of healthcare innovation from laboratory discovery to global clinical adoption..

HealthTech Platform Fund II 不仅是一只风险投资基金，更是推动一个更广泛平台的发展资本引擎，该平台致力于促进全球医疗健康创新。此平台将研究机构、医疗体系、产业界、创业者、家族办公室和资本连接成一个单一的商业化生态系统，旨在加速医疗健康创新从实验室发现到全球临床应用的转化过程。

In conjunction with the launch, Boyd Street Capital announced the appointment of

伴随着此次发布，博伊德街资本宣布任命

Lisa Risser

丽莎·里瑟

as General Partner of HealthTech Platform Fund II. Risser will help lead the fund's investment strategy and commercialization initiatives while working closely with portfolio companies and strategic partners across the healthcare ecosystem.

作为HealthTech Platform Fund II的普通合伙人，Risser将协助领导基金的投资战略和商业化举措，同时与医疗健康生态系统中的被投企业及战略合作伙伴紧密合作。

Boyd Street Capital is building a globally connected healthcare innovation platform through strategic partnerships with research institutions, health systems, founders, investors, and industry leaders. The platform is designed to identify, commercialize, and scale breakthrough healthcare technologies across international markets while accelerating innovation from discovery through clinical adoption.

博伊德街资本（Boyd Street Capital）正通过与研究机构、医疗系统、创业者、投资者及行业领袖建立战略合作伙伴关系，打造一个全球互联的医疗健康创新平台。该平台旨在识别、商业化并将突破性医疗健康技术推广至国际市场，同时加速从发现到临床应用的创新进程。

Through its growing global network, Boyd Street Capital is already facilitating cross-border commercialization initiatives, bringing promising technologies developed outside the United States into the U.S. healthcare market while helping American healthcare innovations expand internationally through strategic partnerships, platform creation, and market access..

凭借日益壮大的全球网络，博伊德街资本（Boyd Street Capital）已在推动跨境商业化举措，将美国境外开发的潜力技术引入美国医疗健康市场，同时通过战略合作伙伴关系、平台搭建和市场准入，助力美国医疗健康创新拓展国际市场。

'Healthcare is entering one of the most transformative periods in its history,' said

“医疗保健行业正步入其历史上最具变革性的时期之一，”

James Spann

詹姆斯·斯潘

, Founder and Chief Executive Officer of Boyd Street Capital. 'The convergence of artificial intelligence, digital health, precision medicine, and new models of care is creating extraordinary opportunities for entrepreneurs and innovators around the world.

，Boyd Street Capital 创始人兼首席执行官。“人工智能、数字健康、精准医疗以及新型护理模式的融合，正在为全球企业家和创新者创造非凡的机遇。

'HealthTech Platform Fund II is more than a venture fund-it is the growth capital investment engine behind a broader healthcare innovation platform designed to accelerate commercialization, strengthen strategic partnerships, and help bring transformative technologies to patients faster. We are building a globally connected platform that moves innovation across borders, connecting world-class research, founders, health systems, industry partners, and capital to accelerate the adoption of healthcare technologies wherever they can create the greatest impact.'.

HealthTech Platform Fund II 不仅仅是一只风险投资基金，它是更广泛的医疗健康创新平台背后的增长资本投资引擎，旨在加速商业化进程、加强战略合作伙伴关系，并帮助将变革性技术更快地带给患者。我们正在构建一个全球互联的平台，推动创新跨越国界，将世界一流的研究机构、创始人、医疗体系、行业合作伙伴和资本连接起来，以加速医疗技术在能够产生最大影响的地方的应用与普及。

HealthTech Platform Fund II will focus its investments across several high-growth sectors, including:

HealthTech Platform Fund II 将重点投资多个高增长领域，包括：

Artificial Intelligence & Clinical Decision Support

人工智能与临床决策支持

Digital Health & Virtual Care

数字健康与虚拟医疗

Medical Devices

医疗器械

Diagnostics

诊断

Healthcare Software

医疗保健软件

Healthcare Infrastructure

医疗基础设施

Care Delivery Innovation

护理服务创新

Healthcare Data & Analytics

医疗数据与分析

Commercialization Technologies

商业化技术

Unlike traditional venture capital funds, Boyd Street Capital's differentiated model extends well beyond providing growth capital. Through its integrated Venture Studio, portfolio companies receive hands-on support in commercialization strategy, executive recruitment, go-to-market planning, strategic partnerships, regulatory planning, operational scaling, and future capital formation..

与传统风险投资基金不同，Boyd Street Capital 的差异化模式远不止提供成长资本。通过其整合型创业工作室，旗下投资组合公司能在商业化战略、高管招聘、市场进入规划、战略合作伙伴关系、监管规划、运营规模化扩张以及后续融资等方面获得实操性支持。

'As we continue building Boyd Street Capital, we are intentionally assembling a leadership team with deep operational experience across every stage of healthcare innovation,' Spann said. 'Lisa Risser brings more than three decades of executive leadership experience in finance and operations within major health systems.

“在持续建设博伊德街资本的过程中，我们有意组建一支在医疗健康创新的各个阶段均拥有深厚运营经验的领导团队，”斯潘恩表示。“丽莎·里瑟在大型医疗体系的财务和运营领域拥有超过三十年的高层领导经验。

Her firsthand understanding of how provider organizations evaluate, purchase, implement, and scale new technologies gives our founders an invaluable strategic advantage as they navigate commercialization. Her experience strengthens our ability to help entrepreneurs build solutions that healthcare organizations are prepared to adopt and scale.'.

她对医疗服务机构如何评估、采购、实施和扩展新技术的第一手了解，为我们的创始人在推进商业化过程中提供了宝贵的战略优势。她的经验增强了我们帮助创业者构建医疗机构愿意采纳并规模化推广的解决方案的能力。

Risser will lead the strategic development and investment activities of HealthTech Platform Fund II while working closely with entrepreneurs, portfolio companies, health systems, research institutions, and strategic partners to accelerate commercialization and company growth.

Risser 将领导 HealthTech Platform Fund II 的战略发展和投资活动，同时与创业者、投资组合公司、医疗系统、研究机构及战略合作伙伴紧密合作，以加速商业化进程和公司增长。

The launch of HealthTech Platform Fund II marks another milestone in Boyd Street Capital's Mission 2030 strategy to build one of the world's leading healthcare innovation and investment platforms.

HealthTech Platform Fund II 的启动标志着 Boyd Street Capital 在“使命2030”战略中又迈出了重要一步，该战略旨在打造全球领先的医疗健康创新与投资平台之一。

The firm expects to announce additional strategic initiatives supporting the continued expansion of its HealthTech Platform in the coming months.

该公司预计在未来几个月内宣布更多战略举措，以支持其健康科技平台的持续扩张。

Founders, strategic partners, and prospective investors interested in learning more about HealthTech Platform Fund II are encouraged to visit

欢迎有意进一步了解 HealthTech Platform Fund II 的创始人、战略合作伙伴及潜在投资者访问

www.boydstreetcap.com

www.boydstreetcap.com

or contact Boyd Street Capital directly.

或直接联系博伊德街资本（Boyd Street Capital）。

About Boyd Street Capital

关于博伊德街资本

Boyd Street Capital is building a global healthcare innovation platform that integrates growth capital, commercialization expertise, platform creation, and strategic partnerships to accelerate the future of healthcare. The firm invests in transformative early-stage healthcare technology companies while providing founders with the operational resources, strategic guidance, and industry relationships needed to build enduring businesses..

博伊德街资本（Boyd Street Capital）正在打造一个全球医疗健康创新平台，整合增长资本、商业化专长、平台构建以及战略合作伙伴关系，以加速医疗健康的未来发展。该公司投资于具有变革性的早期医疗健康技术公司，同时为创始人提供打造持久企业所需的运营资源、战略指导和行业关系。

Through its integrated Venture Studio and an expanding international network of healthcare executives, research institutions, health systems, corporate partners, and investors, Boyd Street Capital is creating pathways for healthcare innovation to move seamlessly across global markets. The platform is already supporting cross-border commercialization initiatives by identifying breakthrough technologies developed internationally for introduction into the U.S.

通过其一体化的创业孵化平台以及不断扩展的由医疗行业高管、研究机构、医疗体系、企业合作伙伴和投资者组成的国际网络，Boyd Street Capital 正在为医疗健康创新无缝跨越全球市场铺平道路。该平台已通过识别国际上开发的突破性技术并引入美国，支持跨境商业化举措。

healthcare system while helping American innovations expand into international markets through strategic partnerships, platform creation, and commercialization support..

医疗保健体系，同时通过战略伙伴关系、平台构建和商业化支持，帮助美国创新成果拓展国际市场。

By connecting capital, clinical expertise, commercialization resources, and strategic relationships on a global scale, Boyd Street Capital is building one of the world's leading healthcare innovation platforms dedicated to accelerating technologies that improve patient outcomes worldwide.

通过在全球范围内整合资本、临床专业知识、商业化资源以及战略关系，Boyd Street Capital 正在打造全球领先的医疗健康创新平台之一，致力于加速推进能够改善全球患者诊疗效果的技术发展。

Media Contact

媒体联系人

Eliza McCloy

伊丽莎·麦克洛伊

Operations Manager

运营经理

Boyd Street Capital

博伊德街资本

[email protected]

[email protected]

SOURCE Boyd Street Capital

来源：博伊德街资本

21

二十一

%

%

more press release views with

更多新闻稿浏览量，通过

Request a Demo

申请演示